The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $7.7 million delivery order to Tulane University under the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ contract. Tulane will develop and utilize a non-human primate model of SARS-CoV-2 infection to support the Institute's research efforts. As the prime contractor, Tulane will leverage its expertise and facilities in New Orleans to conduct the research. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $1.72 million to The Administrators of Tulane Educational Fund, doing business as Tulane University, on September 13, 2024, for Conduct Study 222 under the Simian Vaccine Evaluation Units program. This cost-plus-no-fee delivery order is scheduled for completion by April 11, 2027, with work to be performed in New Orleans, Louisiana. The award carries no set-aside designation, reflecting Tulane's...
The National Institute of Allergy and Infectious Diseases awarded a delivery order valued at $2.18M to The Administrators of Tulane Educational Fund (doing business as Tulane University) on April 1, 2020, to conduct Study P223. This cost-plus-no-fee delivery order falls under the Simian Vaccine Evaluation Units indefinite delivery contract and is scheduled for completion by December 24, 2027. The work will be performed in New Orleans, Louisiana, where Tulane maintains its National Primate...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $1.49 million to The Administrators of Tulane Educational Fund, operating as Tulane University, for maintenance of nonhuman primates in an ABSL2/3 (Animal Biosafety Level 2/3) facility. This delivery order (75N93020D00007/75N93020F00002) is issued under the larger Simian Vaccine Evaluation Units (SVEUS) indefinite delivery contract and will be performed at Tulane's facility in New Orleans,...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract is a delivery order under the "Simian Vaccine Evaluation Units 2013-2020" indefinite delivery contract, with a ceiling value of $9,035,728.24 and a completion date of April 30, 2022. The contract is for "Simian...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,041,214 delivery order contract to Tulane University to conduct a study titled "CONDUCT STUDY P214". This contract is under NIAID's Simian Vaccine Evaluation Units (SVEUS) Indefinite Delivery Contract (IDC), a $146,300,000 multiple-award vehicle for preclinical research support services. The contract has a period of performance through July 23, 2026 and does not contain a set-aside designation. Tulane...
This is a federal contract award to The Administrators Of Tulane Educational Fund, doing business as Tulane University, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The contract, valued at $3,675,463.09, is a delivery order under the Simian Vaccine Evaluation Units (SVEUS) major program. It does not have a set-aside designation. The contract supports NIAID's mission of advancing research to understand, prevent, and treat infectious diseases by...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $6.5 million delivery order to The Administrators of the Tulane Educational Fund, doing business as Tulane University, to serve as the Nonhuman Primate Studies Coordination Center in support of COVID-19-related research at the National Primate Research Centers. This delivery order was issued against the Simian Vaccine Evaluation Units indefinite-delivery/indefinite-quantity master contract to...
This delivery order (75N93020D00007/75N93020F00001) was awarded to Tulane University by the National Institute of Allergy and Infectious Diseases (NIAID) on April 1, 2020, with a ceiling value of $1.85 million and an ultimate completion date of March 31, 2027. The contract provides core administrative and technical support services for the Simian Vaccine Evaluation Units (SVEUS) program, with work to be performed in New Orleans, Louisiana. This delivery order was issued without a set-aside...
This $1,422,288.62 federal delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the Administrators of Tulane Educational Fund, doing business as Tulane University, a private university in New Orleans, Louisiana. The contract is for "Simian Vaccine Evaluation Units" and has an ultimate completion date of June 30, 2020. It is a cost-no-fee contract issued under a...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.37 million delivery order contract to Tulane University under the agency's Preclinical Models of Infectious Diseases 2017-2024 master IDIQ. Tulane will evaluate monovalent vaccines for immunogenicity and efficacy against Venezuelan equine encephalitis and eastern equine encephalitis aerosol challenge in cynomolgus macaques, as outlined under Task Area B-10 of the IDIQ. The two-year period of performance for this task order begins in September 2020. As the prime contractor, Tulane will conduct the preclinical vaccine studies at its facilities in New Orleans, Louisiana. No subcontractors or set aside designations were indicated. The award provides funding for Tulane to evaluate potential vaccines in nonhuman primate models, in support of NIAID's infectious disease research mission.